Exploring the frontiers of iPSC research, clinical application, and standardization

Cell & Gene Therapy Insights 2024; 10(1), 65–73

DOI: 10.18609/cgti.2024.013

Published: 28 February
Julie Allickson

David McCall, Senior Editor, Cell & Gene Therapy Insights, speaks to Julie Allickson, Director of Mayo Clinic, Center for Regenerative Biotherapeutics, about the transformative potential of iPSCs across their potential application areas, including as the foundation for novel cell therapies and in vitro models for drug discovery. Dr Allickson also discusses goals and priorities for driving both technological innovation and standardization in the field.